Highlights Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 04:30:09 18/02/2026 pm IST			5-day change	1st Jan Change
4.700 ^GBX	0.00%		+2.17%	+17.50%

26/12	Certain Ordinary Shares of Poolbeg Pharma PLC are subject to a Lock-Up Agreement Ending on 26-DEC-2025.	CI
08/12	Poolbeg Pharma plc Announces the POLB 001 Trial Is to Feature in Cancer Immunotherapy-Induced CRSResearch Programme	CI

Highlights

08/12	Poolbeg Pharma plc Announces the POLB 001 Trial Is to Feature in Cancer Immunotherapy-Induced CRSResearch Programme	CI
20/11	Poolbeg Pharma Secures European Patent for Severe Influenza Drug Candidate	MT
20/11	Poolbeg Pharma plc Receives European Immunomodulator II Patent Application Covering POLB 001 for the Treatment of Severe Influenza	CI
29/25/29	EARNINGS: Silver Bullet bookings rise; Blackbird hits milestones	AN
29/25/29	Poolbeg Pharma PLC Reports Earnings Results for the Half Year Ended June 30, 2025	CI
26/25/26	Centaur Media to return cash after latest disposal	AN
25/25/25	Poolbeg Pharma plc Signs an Agreement for A Specialist Blood Cancer Trials Organization, Accelerating Clinical Trials Limited to Conduct the Upcoming POLB 001 Phase 2A Trial and Secures the Supply of an Approved Bispecific Antibody Drug for the Trial At No Cost to the Company	CI
27/25/27	Poolbeg Pharma's POLB 001 Wins Orphan Drug Designation in US	MT
23/25/23	Poolbeg upsizes offer; Glenveagh backs outlook	AN
21/25/21	Poolbeg upsizes fundraise amid strong investor demand	AN
20/25/20	Poolbeg Pharma PLC Reports Earnings Results for the Full Year Ended December 31, 2024	CI
20/25/20	Poolbeg Pharma loss widens; launches GBP4 million equity raise	AN
20/25/20	Earnings Flash (POLB.L) Poolbeg Pharma Reports FY24 Loss GBX-1.16	MT
20/25/20	Costain wins deal; Focusrite expects revenue hike	AN
20/25/20	Poolbeg Pharma plc Receives Korean Intellectual Property Office Grant in Korea	CI
21/25/21	AIM WINNERS & LOSERS: Proteome wins deal; Biome plots AIM exit	AN
21/25/21	Poolbeg Pharma Says Hookipa Ended Takeover Talks	MT
21/25/21	FTSE 100 flat as UK data keeps pound above USD1.26	AN
21/25/21	Poolbeg Pharma shares plummet as Hookipa walks away from possible bid	AN
21/25/21	Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger	RE
21/25/21	Hookipa Pharma rules out making offer for Poolbeg Pharma	AN
20/25/20	Poolbeg Pharma PLC cancelled the acquisition of HOOKIPA Pharma Inc. in a reverse merger transaction.	CI
30/25/30	Poolbeg Pharma Extends Deadline for Hookipa Pharma Takeover Talks	MT
10/25/10	Poolbeg Pharma notes Gilead interest in Hookipa fundraise	AN
07/25/07	Poolbeg and Hookipa deal gets support from major stakeholder	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Highlights

Filters